Abstract: High total serum homocysteine (tHcy) concentrations are associated with an increased risk of carotid artery disease in the general population. Since patients with peripheral arterial disease (PAD) have a threefold risk of cerebrovascular morbidity compared to individuals free of PAD, and since the total neurological event rate is associated with a у50% lumen reduction in extracranial carotid arteries, it was tested whether tHcy is a predictor of internal carotid artery stenosis in patients with symptomatic PAD. A total of 443 consecutive male PAD patients without previous carotid surgery/stenting were studied. In all, 100 patients with PAD had an internal carotid artery stenosis у50%. Of the remaining 343 patients, 100 individuals matched for age (±2 years) and diabetes served as controls. The extent of carotid stenosis was evaluated with color duplex measurement; tHcy was determined by high-performance liquid chromatography. Cases displayed a significantly higher median fasting tHcy level (17.0 mol/l) than controls (13.7 mol/l, p = 0.001). Multivariate analysis showed that tHcy (p = 0.036) was an independent predictor of internal carotid artery stenosis Ն50% in PAD patients, representing an odds ratio of 1.32 (95% CI, 1.02-1.72) for an increment of 5 mol/l. In the present study, high tHcy was an independent risk factor for an internal carotid artery stenosis Ն50% in patients with PAD. Since PAD patients suffer a threefold risk of stroke compared to healthy individuals, a simple vitamin substitution in PAD patients may reduce the occurrence of internal carotid artery stenosis and therefore diminish the relatively high rate of cerebrovascular events in this population.
Introduction
An association of hyperhomocysteinemia with atherosclerotic vascular disease was first suggested more than 30 years ago. 1 Numerous cross-sectional and case-control studies have substantiated the initial observation and demonstrated clear associations between total serum homocysteine (tHcy) and the presence of coronary, 2 carotid 3 and peripheral 4 vascular disease. The risk conferred by elevated tHcy is probably independent of other established risk factors 5, 6 and its magnitude is comparable to that of cholesterol. 7 Associations between tHcy and cardiovascular risk factors, such as age and sex or cigarette smoking have been demonstrated as well. 8 Results of the Framingham Study showed that high tHcy values are associated with an increased risk of an extracranial carotid stenosis Ն25% in the general population. 9 Another study demonstrated that even a slightly elevated tHcy concentration is associated with an increased risk of early atherosclerotic carotid artery wall lesions in healthy individuals. 10 Hyperhomocysteinemia is a risk factor both carotid disease and peripheral arterial disease (PAD). This is well portrayed in the literature, as mentioned above, and it is established that patients presenting with symptomatic disease in a particular region of the arterial tree may be suffering from atherosclerotic disease at other sites. Hence, almost all patients with symptomatic PAD may have carotid plaques, but it is not clear why certain PAD patients display hemodynamically relevant stenosis of the extracranial carotid arteries and others do not.
Moreover, there are no published data on whether an association of tHcy concentrations and a stenosis of the extracranial carotid arteries is evident in patients with symptomatic PAD. This association could be clinically important since PAD patients show a higher cerebrovascular morbidity compared to individuals free of symptomatic PAD. 11 Thus, the aim of the present study was to investigate whether tHcy is an independent risk factor of an internal carotid artery stenosis Ն50% in subjects with symptomatic PAD. This cut-off level was chosen because studies suggest that the total neurological event rate (transient ischemic attack, amaurosis fugax and stroke) is associated with the presence of a lumen reduction Ն50%.
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Age and male sex are known to be positively correlated with tHcy values. 8 Since diabetes mellitus is associated with disturbances of lipid transport 13 and impaired renal function, 14 both of which are known to increase tHcy levels, statistical models testing the association of tHcy and carotid artery stenosis become increasingly complex in a population containing such influences. We therefore performed a case-control study with male patients only, and the controls were matched for age and diabetes mellitus in order to correct for underlying metabolic effects. Thus, the main study parameters were tHcy values and the presence of an internal carotid artery stenosis Ն50%. In addition, we evaluated age, current smoking status, hypertension, lipid parameters, diabetes mellitus and serum creatinine (as an indicator of renal function).
Methods
This present study is a case-control study carried out at the Division of Vascular Surgery, Department of Surgery, St John of God Hospital Linz, Austria, and was carried out over a period of 2 years. Male patients who presented with symptoms of PAD (claudication, rest pain, ulceration or gangrene) were recruited consecutively and examined according to standardized procedures explained below. Exclusion criteria included any previous vascular surgery/stenting in one or both internal carotid arteries. Of a total of 443 patients registered at the time of recruitment, 100 had an internal carotid artery stenosis Ն50%. Of the remaining 343 patients, 100 individuals matched for age (±2 years) and diabetes mellitus served as controls. All study participants underwent evaluation for the presence of atherosclerotic risk factors and detailed histories were obtained regarding the presence of symptomatic PAD. Height and weight were routinely measured when patients were hospitalized and the body mass index (BMI) was obtained from the ratio of weight-to-height squared (kg/m 2 ). Clinical examination, chest radiography, a 12-lead electrocardiogram and non-invasive laboratory investigations, consisting of Doppler segmental blood pressure of lower limbs (ATL, HDI 5000) as well as resting anklebrachial index (ABI) measurements, were performed in all study participants. Distal aortofemoral angiography (i. a. DSA, Siemens Multistar TOP) was done in all patients to confirm the presence of PAD and to determine the location and extent of wall changes. For evaluation of carotid bifurcation, color duplex ultrasonography (ATL, HDI 5000) was performed in all study participants. Stenosis of the internal carotid artery Ն50% was defined as acceleration of flow Ն1.4 m/s. In cases where the systolic blood pressure exceeded 145 mmHg or the diastolic blood pressure was above 95 mmHg, or when they were using antihypertensive medication, patients were classified as hypertensive. Diabetes mellitus was defined as the use of glucose-lowering medication or by fasting blood glucose levels Ն126 mg/dl or a glycated hemoglobin (HbA1c) level Ն7.0%. Smoking was specified as the current use of any tobacco.
Blood was collected by venipuncture in vacutainers containing EDTA and vacutainer clot activator tubes (Beckton Dickinson) after an overnight fast at the day of admission to the hospital. Total cholesterol and triglyceride assays were performed by enzymatic methods (CHOD-PAP and GPO-PAP method) and serum creatinine by Jaffè kinetic on a Hitachi 717-analyzer. Glycated hemoglobin (HbA1c) was measured using an ion exchange, high performance liquid chromatography technique (Bio-Rad Variant TM HbA1c
Vascular Medicine 2001; 6: [163] [164] [165] [166] [167] Analyser, Bio-Rad Laboratories). Blood samples for determination of tHcy were centrifuged at 3500 g for 10 min at 4°C immediately after collection, and the serum was separated and stored at −20°C until analysed; tHcy levels were determined by high pressure liquid chromatography (BioRad) 15 once a week. Control samples at two concentrations were supplied by the manufacturer and used to accept or reject individual runs. In addition, to estimate the quality of tHcy analyses in our laboratory, replicate measurements were performed in two patient samples for a period of half a year (corresponding to 26 measurements). The betweenday coefficients of variation in these samples were less than 5%. For determination of high-density lipoprotein cholesterol (HDL cholesterol) and low-density lipoprotein cholesterol (LDL cholesterol), quantitative electrophoresis with densitometric detection (Lipidophor-Immuno Diagnostica) was used. 16 Our laboratory fulfils the quality control criteria of the Austrian External Quality Assurance Program (OEQUASTA).
Statistical analysis was performed with the SPSS 8.0 package. Dichotomous variables are given as prevalence in number (per cent), continuous data are expressed as median (25th-75th percentile). Univariate comparisons of risk factors and other dichotomous variables between study groups were calculated with Fisher's exact test; continuous variables were evaluated with the non-parametric Mann-Whitney U-test (p-values were not adjusted for multiple comparisons and are therefore only descriptive). To identify multivariate risk factors for an internal carotid artery stenosis Ն50% and to determine multivariate odds ratios, logistic regression analysis without variable selection technique was performed. Dichotomous risk factors were coded with an indicator variable of 1 for having the disease and 0 for its absence. Probabilities are generally two-tailed and pvalues less than 0.05 were regarded as statistically significant.
Results
Within the population of 443 PAD patients used in this study, internal carotid artery stenosis Ն50% occurred in 100, which is equivalent to a prevalence of 23%. Of the 443 PAD patients, 278 were free of diabetes mellitus and 165 had diabetes mellitus. In all, 19% (54 patients) of the non-diabetic PAD patients and 28% (46 patients) of the diabetic patients had an internal carotid artery stenosis Ն50%; this difference reached statistical significance (p = 0.046). Table 1 summarizes the data in 100 PAD patients with an internal carotid artery stenosis Ն50% compared to 100 controls with stenosis Ͻ50%. The median (25th-75th percentile) of tHcy values was significantly higher in cases (17.0 mol/l, 12.7-21.3) than in controls (13.7 mol/l, 11.6-16.8; p = 0.001), but no significant differences regarding hypertension, current smoking status, BMI, serum creatinine or lipid parameters could be observed between the study groups, matched for age and diabetes mellitus. Univariate odds ratios of study parameters in the two groups are shown in Table 2 . In addition, Table 3 shows multivariate odds ratios of an internal carotid artery stenosis Ն50% in PAD patients, calculated without variable selection technique including all parameters cited. In the multivariate model, tHcy (p = 0.036) was a significant predictor of casecontrol status with an odds ratio of 1.32 (95% CI, 1.02-1.72) for an increment of 5 mol/l. All other variables failed to reach statistical significance and neither current smoking status, nor hypertension, serum creatinine or lipid parameters revealed significant odds ratios.
Discussion
Similarly to the results of other investigations, 17 marked (Ն50%) stenosis of the internal carotid artery occurred in 23% of the PAD patients examined in this study. This prevalence is higher than in patients with coronary heart disease and markedly higher than in the general population. 18 Since PAD patients show a threefold risk of stroke compared with subjects free of symptomatic PAD, 11 and since a carotid artery stenosis Ն50% is strongly implicated in this risk, 12 a reduction in the development or progression of a carotid artery stenosis Ն50% is highly warranted in these patients.
Patients with symptomatic PAD tend to concentrate on their presenting symptom in the leg and its likely progression. In these individuals, however, a more serious clinical problem is the coexisting arterial disease in the coronary and cerebral circulation, although these may initially be asymptomatic. In several studies, multivariate analyses showed that age, diabetes mellitus, cigarette smoking, systolic blood pressure, and hyperlipidemia were independently related to carotid atherosclerosis in the general population. 19, 20 In contrast, these individual risk factorswith the exception of age -did not predict the detection of a carotid artery stenosis Ն50% in PAD patients. 21 Based on the role of tHcy in atherosclerosis in general, it was therefore of interest whether tHcy concentrations could predict co-morbidity with carotid artery disease in a cohort of PAD patients. In the present case-control study, we determined statistically that tHcy was a risk factor for carotid stenosis Ն50% independently of other covariates known to influence the occurrence or progression of carotid disease in the general population. Thus, increased tHcy concentrations may contribute to the development of hemodynamically relevant stenosis of the internal carotid arteries in patients with symptomatic PAD. This observation could help to explain why certain PAD patients display hemodynamically relevant stenosis of the extracranial carotid arteries and others do not.
A limitation of this study may be the fact that smoking was specified as current use of any tobacco. If prior smokers were evaluated as a separate category, the independent predictive value of tHcy for carotid artery stenosis might have changed. Previous studies have shown that not only current smoking but also a history of cigarette smoking is an important risk factor for atherosclerosis in the general population. 22 However, a previous study revealed that current smokers had distinctly higher tHcy levels than nonsmokers, while no significant difference in tHcy levels was observed between former smokers and never smokers. 8 Because of the apparently transient effect of smoking on tHcy values, we considered the current smoking status to correct for the effect of smoking on tHcy levels.
Since patients with PAD have the highest risk of significant carotid stenosis, 18 routine carotid duplex screening has been generally recommended in this population. 23, 24 Based on the results of the present study we suggest that screening for tHcy should be done in addition to carotid ultrasonography in patients with symptomatic PAD to better identify the population at risk for development or progression of carotid artery stenosis. This suggestion is in accordance with current guidelines to determine levels of tHcy in highrisk patients, including those with arterial occlusive diseases, rather than screening for tHcy in the general population. 25 Several investigations indicate that high tHcy concentrations can be decreased with a vitamin B6, vitamin B12 and/or folate substitution in most cases, 26 but there is no consensus on the optimal dosage of these vitamins for the treatment of elevated tHcy. Not only are clinical trials necessary to determine whether lowering tHcy will reduce vascular disease, but the optimal dose necessary to do so needs to be ascertained as well. Until then, it seems reasonable to attempt to lower tHcy into the normal range using increasing doses or combination therapy if necessary. 27 In this context, a tHcy level less than 10 mol/l has been suggested to be a reasonable therapeutic goal for patients at increased risk, rather than the definition of 'normal values' based on population statistical values of the mean Ϯ 2 SD. 25 As a consequence, not only should the PAD patients with a manifested carotid stenosis Ն50% receive a tHcylowering treatment, but also the patients with a stenosis Ͻ50% and an elevated tHcy level.
There are currently no published data available regarding the efficacy of a tHcy-lowering therapy on cerebrovascular events (especially in patients with symptomatic PAD). There are, however, ongoing clinical trials to test this hypothesis. Until these trials are completed, we may draw conclusions from studies with surrogate outcomes. A recent study has shown that in patients with progression of carotid atherosclerosis, administration of vitamins resulted in a significant reduction in the rate of disease progression and growth of plaque areas. 28 Thus, a simple vitamin substitution may reduce the development or progression of carotid artery stenosis Ն50% in patients with PAD and thereby diminish the high frequency of cerebrovascular Vascular Medicine 2001; 6: [163] [164] [165] [166] [167] complications in this population. However, prospective studies will be necessary to thoroughly clarify this exiting possibility.
